SeaDragon Limited (NZX:SEA) today announces the appointment of Bryan Mogridge to the Board of Directors, with effect from the 1st of February 2019.
Bryan has a BSc in Bio-chemistry and was instrumental in building a solid export base for New Zealand wine. In 1998 he was made an Officer of the New Zealand Order of Merit for his services to the wine industry and in 2008 was inducted into the New Zealand Wine Hall of Fame. Bryan has been a public company director since 1984 and has a wealth of experience, both in executive and board roles. He has also lent his considerable support to not-for-profit organisations such as the Starship Foundation.
SeaDragon also advises that Richard Alderton has resigned, effective on the 31st of January 2019.
Chairman Mark Stewart said: “SeaDragon Directors are very pleased to welcome Mr Mogridge to the Board. We are confident his broad commercial experience and acumen will assist with the future growth and development of the company. We would also like to thank Mr Alderton for his excellent contribution to the development of SeaDragon.”
At SeaDragon’s next meeting of shareholders, shareholders will be asked to elect Bryan Mogridge as a Director.
For the purposes of NZX Main Board Listing Rule 2.6.1, the Board has determined that Bryan Mogridge is an Independent Director.
For further information contact:
Tel: +64 21 332 229
About SeaDragon: www.seadragon.co.nz
SeaDragon Limited (NZX:SEA) is New Zealand’s largest refiner and blender of high-quality, internationally certified concentrated fish oils and fractions, including Omega-3 oils. Our oils are sourced from fish caught in the clean and pure waters around New Zealand, in the Southern Ocean, and elsewhere. We have more than 20 years’ experience processing fish oils and we are recognised for the quality and purity of our products. We supply health supplement manufacturers around the world to meet the burgeoning demand for pure, high-quality fish oils, which are scientifically proven to deliver significant human health benefits such as lowering the risk of heart disease, improving brain function and joint health. The majority of our supply is exported.